Structural characterization of the interactions between CYP51 from Trypanosoma cruzi and Trypanosoma brucei and the antifungal drugs posaconazole and fluconazole

被引：0
|
作者：
Chen, Chiung-Kuang Jack [1 ]
Mckerrow, James H. [2 ]
Podust, Larissa M. [3 ]
机构：
[1] UCSF, San Francisco, CA USA
[2] Sandler Ctr, San Francsico, CA USA
[3] UCSF, San Francsico, CA USA
来源：
FASEB JOURNAL | 2010年 / 24卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Structural Characterization of CYP51 from Trypanosoma cruzi and Trypanosoma brucei Bound to the Antifungal Drugs Posaconazole and Fluconazole
    Chen, Chiung-Kuang
    Leung, Siegfried S. F.
    Guilbert, Christophe
    Jacobson, Matthew P.
    McKerrow, James H.
    Podust, Larissa M.
    PLOS NEGLECTED TROPICAL DISEASES, 2010, 4 (04):
  • [2] CYP51 from Trypanosoma brucei is obtusifoliol-specific
    Lepesheva, GI
    Nes, WD
    Zhou, WX
    Hill, GC
    Waterman, MR
    BIOCHEMISTRY, 2004, 43 (33) : 10789 - 10799
  • [3] Novel structural CYP51 mutation in Trypanosoma cruzi associated with multidrug resistance to CYP51 inhibitors and reduced infectivity
    Franco, Caio H.
    Warhurst, David C.
    Bhattacharyya, Tapan
    Au, Ho Y. A.
    Le, Hai
    Giardini, Miriam A.
    Pascoalino, Bruno S.
    Torrecilhas, Ana Claudia
    Romera, Lavinia M. D.
    Madeira, Rafael Pedro
    Schenkman, Sergio
    Freitas-Junior, Lucio H.
    Chatelain, Eric
    Miles, Michael A.
    Moraes, Carolina B.
    INTERNATIONAL JOURNAL FOR PARASITOLOGY-DRUGS AND DRUG RESISTANCE, 2020, 13 : 107 - 120
  • [4] Targeting Trypanosoma cruzi Sterol 14α-Demethylase (CYP51)
    Lepesheva, Galina I.
    Villalta, Fernando
    Waterman, Michael R.
    ADVANCES IN PARASITOLOGY, VOL 75: CHAGAS DISEASE, PT A, 2011, 75 : 65 - 87
  • [5] Diverse Inhibitor Chemotypes Targeting Trypanosoma cruzi CYP51
    Gunatilleke, Shamila S.
    Calvet, Claudia M.
    Johnston, Jonathan B.
    Chen, Chiung-Kuang
    Erenburg, Grigori
    Gut, Jiri
    Engel, Juan C.
    Ang, Kenny K. H.
    Mulvaney, Joseph
    Chen, Steven
    Arkin, Michelle R.
    McKerrow, James H.
    Podust, Larissa M.
    PLOS NEGLECTED TROPICAL DISEASES, 2012, 6 (07):
  • [6] Trypanosoma brucei CYP51: Essentiality and Targeting Therapy in an Experimental Model
    Dauchy, Frederic-Antoine
    Bonhivers, Melanie
    Landrein, Nicolas
    Dacheux, Denis
    Courtois, Pierrette
    Lauruol, Florian
    Daulouede, Sylvie
    Vincendeau, Philippe
    Robinson, Derrick R.
    PLOS NEGLECTED TROPICAL DISEASES, 2016, 10 (11):
  • [7] Trypanosoma cruzi CYP51 Inhibitor Derived from a Mycobacterium tuberculosis Screen Hit
    Chen, Chiung-Kuang
    Doyle, Patricia S.
    Yermalitskaya, Liudmila V.
    Mackey, Zachary B.
    Ang, Kenny K. H.
    McKerrow, James H.
    Podust, Larissa M.
    PLOS NEGLECTED TROPICAL DISEASES, 2009, 3 (02):
  • [8] Planning new Trypanosoma cruzi CYP51 inhibitors using QSAR studies
    Pedro Igor Camara de Oliveira
    Paulo Henrique de Santana Miranda
    Estela Mariana Guimaraes Lourenço
    Priscilla Suene de Santana Nogueira Silverio
    Euzebio Guimaraes Barbosa
    Molecular Diversity, 2021, 25 : 2219 - 2235
  • [9] In vitro evaluation of arylsubstituted imidazoles derivatives as antiprotozoal agents and docking studies on sterol 14α-demethylase (CYP51) from Trypanosoma cruzi, Leishmania infantum, and Trypanosoma brucei
    Julio Alberto Rojas Vargas
    América García López
    Yulier Pérez
    Paul Cos
    Matheus Froeyen
    Parasitology Research, 2019, 118 : 1533 - 1548
  • [10] In vitro evaluation of arylsubstituted imidazoles derivatives as antiprotozoal agents and docking studies on sterol 14-demethylase (CYP51) from Trypanosoma cruzi, Leishmania infantum, and Trypanosoma brucei
    Rojas Vargas, Julio Alberto
    Garcia Lopez, America
    Perez, Yulier
    Cos, Paul
    Froeyen, Matheus
    PARASITOLOGY RESEARCH, 2019, 118 (05) : 1533 - 1548
12345